Navigation Links
Spindletop Capital Launches Healthcare-Focused Indices
Date:9/3/2013

AUSTIN, Texas, Sept. 3, 2013 /PRNewswire/ -- Spindletop Capital, a healthcare-focused investment firm, has announced the launch of five stock market indices tracking healthcare sectors.

(Logo: http://photos.prnewswire.com/prnh/20130903/DA73222LOGO)

"The focus of our Spindletop™ stock indices is to complement our current investment strategy," says Dr. Evan Melrose, Managing Director of Spindletop Capital. "In an effort to better track healthcare performance and the rotations of various healthcare segments for our partners, we have created several Spindletop Indices.  Our best performing index, the Spindletop™ US Biotechnology Index, is up 35.0% YTD."  Year to date, the indices have outperformed the S&P by an average of 8.5%. 

"Over 100 years ago, the discovery of oil at Spindletop signaled the beginning of the oil boom in Texas," adds Dr. Melrose.  "We believe the next 'Spindletop' for Texas will be healthcare tracked by the Spindletop™ Texas Healthcare Index, which is up 13.8% YTD." 

The following Spindletop™ stock indices track different sectors of healthcare:  

Spindletop™ US Medical Device Index  (up 21.4% YTD)

Spindletop™ US Biotechnology Index  (up 35.0% YTD)

Spindletop™ US Pharmaceutical Index  (up 8.5% YTD)

Spindletop™ US Healthcare Services Index  (up 26.8% YTD)

Spindletop™ Texas Healthcare Index  (up 13.8% YTD)

Each index contains a portfolio of 25 or more stocks that meet the criteria set by Spindletop Capital's proprietary algorithms.

About Spindletop
Spindletop Capital, founded in 2011, is a healthcare investment firm focused on providing expansion capital for commercial stage healthcare companies. Based in Austin, Spindletop is managed by an unrivaled team of investment professionals and advisors with deep operating, technical, and transactional experience. Spindletop Capital leverages the organization's deep experience, broad network and proprietary access to Texas resources to create incremental value for management teams and financing syndicates.  Spindletop Capital invests nationally across all sectors of healthcare including medical devices, diagnostics, healthcare services, healthcare IT, specialty pharmaceuticals and biotechnology.

Media Contact:

Wendy Easterling
Spindletop Capital
512-961-4633
Wendy[AT]Spindletopcapital.com

 

 

 


'/>"/>
SOURCE Spindletop Capital
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Creekridge Capital Expands Healthcare Sales Team
2. Sanomedics Receives Financing for Working Capital and Acquisitions
3. Yew Bio-Pharm Group Announces Coverage by S&P Capital IQ
4. Creekridge Capital Adds Revolving Credit Specialist
5. Japan Vietnam Medical Instrument Company Announces $7M Capital Raise
6. Generex Announces $1,225,000 Capital Investment
7. Blackford Capital Acquires Medical Equipment Maker Mopec, Inc.
8. MGT Capital Investments, Inc. Announces Sale of Medicsight Patents
9. BioElectronics Receives Working Capital Infusion
10. MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference
11. Edgemont Capital Completes Sale Of Vince & Associates Clinical Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 /PRNewswire/ ... ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic ... safety and tolerability profile of ropeginterferon alfa-2b versus HU ... the ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing ... to present this data to the FDA as it seeks ...
(Date:12/4/2016)... -- Sickle cell disease (SCD) is an inherited chronic ... get stuck in veins and block blood flow, which ... leading to death. Each year, approximately 300,000 people around ... them lack access to comprehensive care or effective treatment ... SCD, a pill called hydroxyurea approved more than a ...
(Date:12/2/2016)... SILVER SPRING, Md. , Dec. 2, 2016 /PRNewswire-USNewswire/ ... a new indication for Jardiance (empagliflozin) to reduce the ... 2 diabetes mellitus and cardiovascular disease. ... adults with type 2 diabetes mellitus," said Jean-Marc ... Metabolism and Endocrinology Products in FDA,s Center for Drug ...
Breaking Medicine Technology:
(Date:12/4/2016)... NY (PRWEB) , ... December 03, 2016 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – hosted its first Swirl: A Wine Tasting Event in New York City, ...
(Date:12/4/2016)... ... December 03, 2016 , ... Houston ... the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging Medicine ... Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, speakers, ...
(Date:12/4/2016)... (PRWEB) , ... December 04, 2016 , ... ... undergoing major cosmetic surgery can now take advantage of a cosmetic procedure known ... skin rejuvenation treatment that reduces the appearance of age spots, fine lines, ...
(Date:12/2/2016)... ... December 02, 2016 , ... Halfway through its partnership with ... preventative dental services to more than 15,900 children 5 years old and younger and ... $38 million over a span of five years to Western University of Health Sciences, ...
(Date:12/2/2016)... ... 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will host the ... the 2016 MPN Heroes—eight individuals who have made a difference in the field of ... standard of care, demonstrating leadership within the MPN community and/or a commitment to individual ...
Breaking Medicine News(10 mins):